Neoadjuvant chemotherapy in advanced ovarian cancer: what kind of evidence is needed to convince US gynaecological oncologists?
Vergote
Ignace
I
Amant
Frederic
F
Leunen
Karin
K
D017024:Chemotherapy, Adjuvant; D005260:Female; D006176:Gynecology / Q000379:methods*; D006801:Humans; D008495:Medical Oncology / Q000379:methods*; D020360:Neoadjuvant Therapy; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000601:surgery; D010818:Practice Patterns, Physicians'; D014481:United States